REQUEST A DEMO
Total
USD $0.00
Search more companies

Sau Pharma Private Limited (India)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sau Pharma Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sau Pharma Private Limited is an enterprise based in India. Its main office is in Mumbai. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on March 12, 2011. The company’s latest financial report indicates a net sales revenue increase of 18.4% in 2024. Its’ total assets recorded a growth of 6.96%. The net profit margin of Sau Pharma Private Limited decreased by 0.24% in 2024.

Legal Address
Rapher Chawl, Sai Baba Road, Jawahar Nagar, Khar East
Mumbai; Maharashtra; Postal Code: 400051

Contact Details: Purchase the Sau Pharma Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Sau Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the Sau Pharma Private Limited report to view the information.
Incorporation Date:
March 12, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Additional Executive Director
Purchase this report to view the information.
Additional Executive Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Sau Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
18.4%
Total Operating Revenue
18.4%
Operating Profit
-9.41%
EBITDA
-9.41%
Net Profit/Loss for the Period
-15.72%
Total Assets
6.96%
Total Equity
23.99%
Operating Profit Margin
-0.28%
Net Profit Margin
-0.24%
Return on Equity (ROE)
-9.11%
Debt / Equity
-46%
Quick Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?